Tactile Systems Technology (NASDAQ: TCMD) and Entellus Medical (NASDAQ:ENTL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitabiliy, risk, earnings, valuation, analyst recommendations, dividends and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations and price targets for Tactile Systems Technology and Entellus Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology 0 0 4 0 3.00
Entellus Medical 1 2 4 0 2.43

Tactile Systems Technology currently has a consensus target price of $33.00, suggesting a potential downside of 0.99%. Entellus Medical has a consensus target price of $22.00, suggesting a potential upside of 28.06%. Given Entellus Medical’s higher possible upside, analysts plainly believe Entellus Medical is more favorable than Tactile Systems Technology.

Profitability

This table compares Tactile Systems Technology and Entellus Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tactile Systems Technology 2.24% 4.82% 3.28%
Entellus Medical -41.11% -66.04% -38.94%

Valuation and Earnings

This table compares Tactile Systems Technology and Entellus Medical’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Tactile Systems Technology $90.69 million 6.23 $4.01 million $0.09 370.37
Entellus Medical $77.39 million 4.87 -$25.43 million ($1.66) -10.35

Tactile Systems Technology has higher revenue and earnings than Entellus Medical. Entellus Medical is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

34.7% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 76.8% of Entellus Medical shares are held by institutional investors. 49.9% of Tactile Systems Technology shares are held by company insiders. Comparatively, 9.1% of Entellus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Tactile Systems Technology beats Entellus Medical on 9 of the 11 factors compared between the two stocks.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.

Entellus Medical Company Profile

Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company’s XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

Receive News & Ratings for Tactile Systems Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.